EQT Corporation EQT Innovation Pipeline Q4 2025 EPS Exceeds Expectations Halozyme Therapeutics HALO revenue climbs 375 YoY despite steep earnings miss investors parse guidance amid cost concerns Is Primoris PRIM stock overvalued Investor Interest 20260418 Tempus AI ILMN Strategic Entry Point Emerges as Platform Transformation Accelerates JNJ Q1 2026 Earnings EPS Slightly Beats Estimates No Revenue Data Disclosed Doximity Inc DOCS Q1 2026 Earnings EPS Misses Estimates Stock Still Rises XPO Q1 2026 Earnings EPS Surges 14 Above Estimates Stock Eases BOTJ Q1 2025 Earnings Positive EPS Performance Amidst Limited Guidance Visibility ArrowMark Financial Corp BANX Q4 2022 Earnings EPS Misses Estimates by 196 Stock Declines Gladstone Capital Corporation GLAD Q1 2026 Earnings EPS Misses Estimates by 206 Stock Gains 09